211
Participants
Start Date
October 31, 2013
Primary Completion Date
September 30, 2016
Study Completion Date
November 30, 2016
Biomarker-based diagnostic
The intervention will be a biomarker-based diagnostic test for the exclusion of VAP
Royal Victoria Hospital, Belfast
Wansbeck General Hospital, Ashington
Sandwell and West Birmingham, Birmingham
Russells Hall Hospital, Dudley
Western General Hospital, Edinburgh
Queen Elizabeth Hospital, Gateshead
Royal Liverpool Hospital, Liverpool
Manchester Royal Infirmary, Manchester
James Cook University Hospital, Middlesbrough
Freeman Hospital, Newcastle upon Tyne
Sunderland Royal Hospital, Sunderland
Birmingham Heartlands Hospital, Birmingham
Countess of Chester Hospital, Chester
University Hospital Coventry, Coventry
Edinburgh Royal Infirmary, Edinburgh
Chelsea and Westminster Hospital, London
North Tyneside General Hospital, North Shields
Royal Preston Hospital, Preston
Salford Royal Hospital, Salford
Wellcome Trust
OTHER
Newcastle-upon-Tyne Hospitals NHS Trust
OTHER